Loading...

Ribavirin Impairs Salivary gland function During Combination Treatment With Pegylated Interferon Alfa-2a In HEpatitis C patients

BACKGROUND: Xerostomia is a common adverse event of unknown etiology observed during pegylated interferon (PegIFN)/Ribavirin (Rbv) treatment. OBJECTIVES: To assess the frequency and mechanisms of xerostomia during PegIFN/Rbv therapy. PATIENTS AND METHODS: Thirty-one naïve patients with chronic hepat...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Aghemo, Alessio, Rumi, Maria Grazia, Monico, Sara, Banderali, Matteo, Russo, Antonio, Ottaviani, Francesco, Vigano, Mauro, D’Ambrosio, Roberta, Colombo, Massimo
Format: Artigo
Sprog:Inglês
Udgivet: Kowsar 2011
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3269061/
https://ncbi.nlm.nih.gov/pubmed/22308157
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/kowsar.1735143X.733
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!